Cited by 77Cerebrovascular and Carotid Artery DiseasesLipoproteins and Cardiovascular HealthAcute Ischemic Stroke Management

Statins: an essential component in the management of carotid artery disease

Open access
Paraskevas, Kosmas I., Hamilton, George, Mikhailidis, Dimitri P.·2007·Journal of Vascular Surgery

Abstract

Objective We aimed to define the role of treatment using statins (3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors) in the management of patients with carotid artery disease.Literature search methods We searched PubMed for studies evaluating the effect of statins on carotid IMT and the occurrence of cerebrovascular events.Literature search results Current evidence indicates that routine statin therapy reduces carotid intima-media thickness progression and stroke risk. Additionally, statin treatment significantly reduces perioperative as well as long-term morbidity and mortality in patients undergoing carotid surgery or endovascular interventions. It would also be expected that statins would reduce coronary events in this high-risk population.Conclusions Statins should be considered as an essential component of the therapeutic approach of patients with carotid artery stenosis.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jvs.2007.03.035

Cites

167 of 167 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • A more recent systematic review showed significant carotid intima-media thickness regression after statin therapy.

    “and a more recent systematic review also showed a significant CIMT regression after statin therapy.204”

    From ESC/EAS Guidelines for the management of dyslipidaemias (2011) · cites this paper as [204]

  • Two systematic reviews, mostly based on retrospective nonrandomized studies, found inconclusive evidence that statin therapy reduces perioperative cardiovascular morbidity and mortality in abdominal aortic aneurysm patients.

    “Two systematic reviews, 204,207 mostly based on retrospective nonrandomized studies, reported that there is still inconclusive evidence that statin therapy reduces the perioperative CV morbidity and mortality in these patients.”

    From ESC/EAS Guidelines for the management of dyslipidaemias (2011) · cites this paper as [204]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Part of this paper’s reference list could not be split into single entries.

Flagged first, then by citations

2 of the 169 references couldn’t be matched to a known paper.

Research works printed but not linked: 5

  1. Tsiara S, Elisaf M, Mikhailidis DP. Early vascular benefits of statins. Curr Med Res Opin 2003;19:540-6.
  2. Amarenco P, Bogousslavsky J, Callahan A 3rd, Goldstein LB, Hen- nerici M, Rudolph AE, et al; Stroke Prevention by Aggressive Reduc- tion in Cholesterol Levels (SPARCL) Investigators. High-dose ator- vastatin after stroke of transient ischemic attack. N Engl J Med 2006;355:549-59.
  3. Results of low-dose (20 mg) pravastatin GISSI Prevenzione Trial in 4271 patients with recent myocardial infarction: do stopped trials contribute to overall knowledge? GISSI Prevenzione Investigators (Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Mio- cardico). Ital Heart J 2000;1:810-20.
  4. Nemerson Y. Tissue factor and hemostasis. Blood 1988;71:1-8.
  5. Rosenson RS, Tangney CC. Antiatherothrombotic properties of st- atins: implications for cardiovascular event reduction. JAMA 1998; 279:1643-50.

Cited by

Sorted by citations

Authors
Paraskevas, K. I., Hamilton, G., & Mikhailidis, D. P.
Affiliations
The Royal Free Hospital (GB)
Corresponding author
Mikhailidis, Dimitri P.
Venue
Journal of Vascular Surgery
Publisher
Elsevier BV
Published
2007-08
Volume
46
Issue
2
Pages
373-386.e9
ISSN
0741-5214 (ISSN-L)
OpenAlex
W2103876289
Cited by
77
References
169
Citations by year
2025: 4 · 2024: 2 · 2023: 1 · 2022: 2 · 2021: 1 · 2020: 4 · 2019: 2 · 2018: 3 · 2017: 6 · 2016: 5 · 2015: 4 · 2014: 3 · 2013: 2 · 2012: 1
FWCI
1.58
Type
journal article
Language
en
Open access
Locations
  • Journal of Vascular Surgery (publishedVersion)
  • PubMed (publishedVersion)
  • UCL Discovery (University College London) (submittedVersion)
Topics
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Cerebrovascular and Carotid Artery Diseases
  • Health Sciences › Medicine › Surgery › Lipoproteins and Cardiovascular Health
  • Health Sciences › Medicine › Epidemiology › Acute Ischemic Stroke Management
Keywords
statins, carotid artery stenosis, carotid intima-media thickness, stroke risk, cerebrovascular events, carotid endarterectomy, coronary events
MeSH terms
Carotid Arteries, Coronary Disease, Humans, Risk Factors, Carotid Stenosis, Treatment Outcome, Practice Guidelines as Topic, Tunica Intima, Tunica Media, Risk Assessment, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Stroke

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review